WORLD JOURNAL OF PLASTIC SURGERY
Sun, Dec 14, 2025
[Archive]
Volume 14, Issue 3 (2025)
WJPS 2025, 14(3): 108-109 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Grillo R, Samieirad S, Reis B A Q, Lima B C, Elias F M. Semaglutide Awareness in Maxillofacial Surgery. WJPS 2025; 14 (3) :108-109
URL: http://wjps.ir/article-1-1542-en.html
URL: http://wjps.ir/article-1-1542-en.html
Ricardo Grillo *1 
, Sahand Samieirad2 , Bruno Alvarez Quinta Reis1 , Bernardo Correia Lima3 , Fernando Melhem- Elias4
, Sahand Samieirad2 , Bruno Alvarez Quinta Reis1 , Bernardo Correia Lima3 , Fernando Melhem- Elias4
1- Oral and Maxillofacial Surgery Training Program, Foundation of Dentistry - Fundecto, University of São Paulo, São Paulo, Brazil
2- Department of Oral and Maxillofacial Surgery, Mashhad Dental School, Mashhad University of Medical Sciences, Mashhad, Iran.
3- Oral Diagnosis, Dental Radiology and Imaging Postgraduate Program, School of Dentistry, University of São Paulo, São Paulo, Brazil
4- Department of Oral and Maxillofacial Surgery, University of São Paulo School of Dentistry, São Paulo-SP, Brazil.
2- Department of Oral and Maxillofacial Surgery, Mashhad Dental School, Mashhad University of Medical Sciences, Mashhad, Iran.
3- Oral Diagnosis, Dental Radiology and Imaging Postgraduate Program, School of Dentistry, University of São Paulo, São Paulo, Brazil
4- Department of Oral and Maxillofacial Surgery, University of São Paulo School of Dentistry, São Paulo-SP, Brazil.
Abstract: (365 Views)
Semaglutide, a once-weekly GLP-1 receptor agonist, has emerged as a promising therapeutic option for individuals struggling with obesity and type 2 diabetes mellitus (T2DM). Its ability to induce weight loss, reduce appetite, and improve glycemic control has led to its increasing utilization in clinical practice. Semaglutide works by mimicking the action of endogenous GLP-1, leading to enhanced insulin secretion, decreased glucagon secretion, and delayed gastric emptying
References
1. Wang L, Wang N, Zhang W, Cheng X, Yan Z, Shao G, et al. Therapeutic peptides: current applications and future directions. Signal Transd Target Ther 2022;7:1-27. [DOI:10.1038/s41392-022-00904-4]
2. Klein SR, Hobai IA. Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report. Can J Anaesth 2023;70:1394-6. [DOI:10.1007/s12630-023-02440-3]
3. Jones PM, Hobai IA, Murphy PM. Anesthesia and glucagon-like peptide-1 receptor agonists: proceed with caution! Can J Anaesth 2023;70:1281-6. [DOI:10.1007/s12630-023-02550-y]
4. Avraham SA, Hossein J, Somri F, Hawash N, Hochman O. Pulmonary aspiration of gastric contents in two patients taking semaglutide for weight loss. Anaesth Rep 2024;12:12278. [DOI:10.1002/anr3.12278]
5. Chan PYW, Mika AP, Martin JR, Wilson JM. Glucagon-like Peptide-1 Agonists: What the Orthopaedic Surgeon Needs to Know. JBJS Rev 2024;12. [DOI:10.2106/JBJS.RVW.23.00167]
6. Queiroz VNF, Falsarella PM, Chaves RC de F, Takaoka F, Socolowski LR, Garcia RG. Risk of pulmonary aspiration during semaglutide use and anesthesia in a fasting patient: a case report with tomographic evidence. Einstein (Sao Paulo) 2023;21:eRC0628. [DOI:10.31744/einstein_journal/2023RC0628]
7. Marino EC, Negretto L, Ribeiro RS, Momesso D, Feitosa ACR, Bertoluci M. [Rastreio e Controle da Hiperglicemia no Perioperatório]. Braz Diabetes Soc 2023.
8. American Society of Anesthesiologists. American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists | American Society of Anesthesiologists (ASA).
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
